Literature DB >> 17634215

Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004.

O O'Toole1, B J Traynor, P Brennan, C Sheehan, E Frost, B Corr, O Hardiman.   

Abstract

BACKGROUND: We conducted a prospective, population based study to examine trends in incidence and prevalence of amyotrophic lateral sclerosis (ALS) in Ireland from 1995 to 2004.
METHODS: The Irish ALS Register was used to identify Irish residents diagnosed with ALS between the 3 year period from 1 January 1995 to 31 December 1997 and the 3 year period from 1 January 2002 to 31 December 2004.
RESULTS: 465 Irish residents were diagnosed with ALS during the study periods. The annual incidence rate of ALS in Ireland remained stable over this time (2.0 cases per 100,000 person-years; 95% CI 1.9, 2.2). Median survival of Irish ALS patients was 16.4 months and did not change during the study period. Demographics and clinical features of the incident and prevalent Irish ALS cohorts were markedly different.

Entities:  

Mesh:

Year:  2007        PMID: 17634215     DOI: 10.1136/jnnp.2007.117788

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  60 in total

1.  Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics.

Authors:  Henrik Ryberg; Jiyan An; Samuel Darko; Jonathan Llyle Lustgarten; Matt Jaffa; Vanathi Gopalakrishnan; David Lacomis; Merit Cudkowicz; Robert Bowser
Journal:  Muscle Nerve       Date:  2010-07       Impact factor: 3.217

Review 2.  Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin.

Authors:  Benoît Marin; Giancarlo Logroscino; Farid Boumédiene; Anaïs Labrunie; Philippe Couratier; Marie-Claude Babron; Anne Louise Leutenegger; Pierre Marie Preux; Ettore Beghi
Journal:  Eur J Epidemiol       Date:  2015-10-12       Impact factor: 8.082

Review 3.  Diagnosis and management of motor neurone disease.

Authors:  Christopher J McDermott; Pamela J Shaw
Journal:  BMJ       Date:  2008-03-22

4.  Multiparametric MRI study of ALS stratified for the C9orf72 genotype.

Authors:  Peter Bede; Arun L W Bokde; Susan Byrne; Marwa Elamin; Russell L McLaughlin; Kevin Kenna; Andrew J Fagan; Niall Pender; Daniel G Bradley; Orla Hardiman
Journal:  Neurology       Date:  2013-06-14       Impact factor: 9.910

5.  The epidemiology of motor neurone disease in two counties in the southwest of England.

Authors:  Ibrahim Imam; Susan Ball; Dave Wright; C Oliver Hanemann; John Zajicek
Journal:  J Neurol       Date:  2010-01-22       Impact factor: 4.849

Review 6.  Emerging mechanisms of molecular pathology in ALS.

Authors:  Owen M Peters; Mehdi Ghasemi; Robert H Brown
Journal:  J Clin Invest       Date:  2015-05-01       Impact factor: 14.808

Review 7.  Presymptomatic studies in ALS: rationale, challenges, and approach.

Authors:  Michael Benatar; Joanne Wuu
Journal:  Neurology       Date:  2012-10-16       Impact factor: 9.910

8.  Changing mortality for motor neuron disease in France (1968-2007): an age-period-cohort analysis.

Authors:  Paul H Gordon; Fanny Artaud; Albertine Aouba; Françoise Laurent; Vincent Meininger; Alexis Elbaz
Journal:  Eur J Epidemiol       Date:  2011-06-15       Impact factor: 8.082

Review 9.  Clinical diagnosis and management of amyotrophic lateral sclerosis.

Authors:  Orla Hardiman; Leonard H van den Berg; Matthew C Kiernan
Journal:  Nat Rev Neurol       Date:  2011-10-11       Impact factor: 42.937

10.  Updated Prevalence and Demographic Characteristics for ALS Cases in Texas, 2009-2011.

Authors:  Lindsay Rechtman; Laurie Wagner; Wendy Kaye; John Villanacci
Journal:  South Med J       Date:  2015-08       Impact factor: 0.954

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.